What is the address of DOKTER THOMAS MARYNISSEN, CARDIOLOOG?

The registered office of DOKTER THOMAS MARYNISSEN, CARDIOLOOG is located at Dorpstraat 709, 3061 Bertem.

Is DOKTER THOMAS MARYNISSEN, CARDIOLOOG still active?

Yes. According to the CBE (31 October 2026) DOKTER THOMAS MARYNISSEN, CARDIOLOOG is active, legal situation “Normale toestand”, started on 19 May 2020.

Is DOKTER THOMAS MARYNISSEN, CARDIOLOOG registered on Peppol?

No, DOKTER THOMAS MARYNISSEN, CARDIOLOOG is currently not registered on the Peppol network.

What is the enterprise number of DOKTER THOMAS MARYNISSEN, CARDIOLOOG?

The enterprise number of DOKTER THOMAS MARYNISSEN, CARDIOLOOG is BE0747475763.

When was DOKTER THOMAS MARYNISSEN, CARDIOLOOG founded?

DOKTER THOMAS MARYNISSEN, CARDIOLOOG was founded on 19 May 2020.

Is DOKTER THOMAS MARYNISSEN, CARDIOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 May 2020; 4 annual accounts filed, latest fiscal year 2025.

How much profit did DOKTER THOMAS MARYNISSEN, CARDIOLOOG make in 2025?

DOKTER THOMAS MARYNISSEN, CARDIOLOOG posted a profit after taxes of € 168,526 in financial year 2025.

What is the revenue of DOKTER THOMAS MARYNISSEN, CARDIOLOOG?

As a small company, DOKTER THOMAS MARYNISSEN, CARDIOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 270,683.

DOKTER THOMAS MARYNISSEN, CARDIOLOOG (Private Limited)

Dossier DOKTER THOMAS MARYNISSEN, CARDIOLOOG, printed on 31 October 2026 from databakkes.be/en/0747475763/dokter-thomas-marynissen-cardioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DOKTER THOMAS MARYNISSEN, CARDIOLOOG from Bertem, company number BE0747475763, closed financial year 2025 with a result of € 168,526 after tax. For that financial year DOKTER THOMAS MARYNISSEN, CARDIOLOOG recorded a gross margin of € 270,683 and equity of € 20,000. Compared with financial year 2024, the result moved from € 270,571 to € 168,526. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 9, 2025.

What it is worth Healthy

€ 20,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 168,526

▼ 38% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 55,267

▲ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 168,526 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 3,663

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,254

▲ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,157

▼ 81% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 138,754 Gross margin 2022: € 138,754 First fiscal year in the series	€ 161,322 Gross margin 2023: € 161,322 ▲ 16% vs 2022 (€ 138,754) Favourable step	€ 413,354 Gross margin 2024: € 413,354 ▲ 156% vs 2023 (€ 161,322) Favourable step	€ 270,683 Gross margin 2025: € 270,683 ▼ 35% vs 2024 (€ 413,354) Unfavourable step	▼ 35%
Profit after taxes	€ 106,054 Profit after taxes 2022: € 106,054 First fiscal year in the series	€ 122,591 Profit after taxes 2023: € 122,591 ▲ 16% vs 2022 (€ 106,054) Favourable step	€ 270,571 Profit after taxes 2024: € 270,571 ▲ 121% vs 2023 (€ 122,591) Favourable step	€ 168,526 Profit after taxes 2025: € 168,526 ▼ 38% vs 2024 (€ 270,571) Unfavourable step	▼ 38%
Equity	€ 169,879 Equity 2022: € 169,879 First fiscal year in the series	€ 192,469 Equity 2023: € 192,469 ▲ 13% vs 2022 (€ 169,879) Favourable step	€ 20,000 Equity 2024: € 20,000 ▼ 90% vs 2023 (€ 192,469) Unfavourable step	€ 20,000 Equity 2025: € 20,000 Unchanged (€ 20,000) Unchanged
Total debts	€ 33,761 Total debts 2022: € 33,761 First fiscal year in the series	€ 40,137 Total debts 2023: € 40,137 ▲ 19% vs 2022 (€ 33,761) Unfavourable step	€ 354,051 Total debts 2024: € 354,051 ▲ € 313,914 vs 2023 (€ 40,137) Unfavourable step	€ 182,204 Total debts 2025: € 182,204 ▼ 49% vs 2024 (€ 354,051) Favourable step	▼ 49%
Cash	€ 196,501 Cash 2022: € 196,501 First fiscal year in the series	€ 227,150 Cash 2023: € 227,150 ▲ 16% vs 2022 (€ 196,501) Favourable step	€ 52,784 Cash 2024: € 52,784 ▼ 77% vs 2023 (€ 227,150) Unfavourable step	€ 55,267 Cash 2025: € 55,267 ▲ 5% vs 2024 (€ 52,784) Favourable step	▲ 5%
Retained profit	€ 166,879 Retained profit 2022: € 166,879 First fiscal year in the series	€ 189,469 Retained profit 2023: € 189,469 ▲ 14% vs 2022 (€ 166,879) Favourable step	€ 17,000 Retained profit 2024: € 17,000 ▼ 91% vs 2023 (€ 189,469) Unfavourable step	€ 17,000 Retained profit 2025: € 17,000 Unchanged (€ 17,000) Unchanged
Dividend	€ 12,000 Dividend 2022: € 12,000 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 ▲ € 88,000 vs 2022 (€ 12,000) Unchanged	€ 443,041 Dividend 2024: € 443,041 ▲ € 343,041 vs 2023 (€ 100,000) Unchanged	€ 168,526 Dividend 2025: € 168,526 ▼ 62% vs 2024 (€ 443,041) Unchanged	▼ 62%
Balance sheet total	€ 203,640 Balance sheet total 2022: € 203,640 First fiscal year in the series	€ 232,606 Balance sheet total 2023: € 232,606 ▲ 14% vs 2022 (€ 203,640) Unchanged	€ 374,051 Balance sheet total 2024: € 374,051 ▲ 61% vs 2023 (€ 232,606) Unchanged	€ 202,204 Balance sheet total 2025: € 202,204 ▼ 46% vs 2024 (€ 374,051) Unchanged	▼ 46%

Key figures of DOKTER THOMAS MARYNISSEN, CARDIOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DOKTER THOMAS MARYNISSEN, CARDIOLOOG?

What happened at DOKTER THOMAS MARYNISSEN, CARDIOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 9, 2025 New annual accounts for financial year 2025: profit of € 168,526 (▼ 38% vs 2024). Source: NBB ↗
May 19, 2020 New establishment in Bertem. KBO
May 19, 2020 Start of the company according to the CBE. KBO

In short

From € 106,054 profit in 2022 to € 168,526 profit in 2025.

Paid € 208,825 in corporate taxes since 2022.

Best year ever: 2024, with € 270,571 profit.

Paid out € 723,567 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpstraat 709

3061 Bertem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0747.475.763
VAT number: BE 0747.475.763
Registered office: Dorpstraat 709, 3061 Bertem
Names & denominations: DOKTER THOMAS MARYNISSEN, CARDIOLOOG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 May 2020
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

DOKTER THOMAS MARYNISSEN, CARDIOLOOG